Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

IPIX President and Chief Medical Officer said this in the context of the new licensing agreement announced Monday morning, and I highlighted in bold an overlooked aspect. Why would he say "human testing anticipated to start as soon as year-end" if the company did not know where funding would be coming from?

The statement tells me they do know.

... we’re excited to be underway with our own Brilacidin oral formulation efforts to treat more extensive forms of IBD. We currently are utilizing sophisticated, controlled-release tablet technology to enable targeted delivery of oral Brilacidin in the colon, with in-human testing anticipated to start as soon as year-end.